In an article for the Wall Street Journal, it was noted that Cambrex Corporation is a forward-thinking life sciences company that is focused on developing products, services, and technologies that will speed up the commercialization and development of small molecule therapeutics. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates, and enhanced drug delivery products targeting both branded and generic pharmaceuticals. Cambrex Corporation has an extensive range of manufacturing capabilities, which includes enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances, and formulation of finished dosage form products.